Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Borg

Showing results (11-20 of 224) with videos related to

Pageof 23
Sort By:
Journal of Chemical Information and Modeling|August 2, 2016
Selective Inhibition of STAT3 with Respect to STAT1: Insights from Molecular Dynamics and Ensemble Docking SimulationsSemen O Yesylevskyy, Christophe Ramseyer, Marc Pudlo, et al.
Cancers|January 11, 2022
Harnessing Antitumor CD4<sup>+</sup> T Cells for Cancer ImmunotherapyMyriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, et al.
Annals of Gastroenterology|May 23, 2024
Comparison of a selective STAT3 inhibitor with a dual STAT3/STAT1 inhibitor using a dextran sulfate sodium murine colitis model: new insight into the debate on selectivityBrice Moulari, Jean-Réné Pallandre, Arnaud Béduneau, et al.
Frontiers in Immunology|July 15, 2021
Epigenetic Reprogramming of CD4<sup>+</sup> Helper T Cells as a Strategy to Improve Anticancer ImmunotherapyElodie Renaude, Marie Kroemer, Christophe Borg, et al.
Bulletin Du Cancer|November 12, 2003
[NK cell-based immunotherapy: new prospects and involvement of dendritic cells]Christophe Borg, Julien Taieb, Magali Terme, et al.
Cancers|August 7, 2021
Present and Future Research on Anal Squamous Cell CarcinomaLaurie Spehner, Jihane Boustani, Luc Cabel, et al.
Cancer Gene Therapy|October 14, 2021
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cellsChrystel Marton, Patricia Mercier-Letondal, Romain Loyon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinomaAntoine Thiery-Vuillemin, Caroline Laheurte, Laura Mansi, et al.
Clinical and Vaccine Immunology : CVI|May 31, 2013
Human monocyte-derived dendritic cells exposed to microorganisms involved in hypersensitivity pneumonitis induce a Th1-polarized immune responseAnne-Pauline Bellanger, Jean-René Pallandre, Christophe Borg, et al.
Oncotarget|June 8, 2018
Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinomaAnne Aarnink, Corentin Richard, Caroline Truntzer, et al.
Pageof 23

Showing results (11-20 of 224) with videos related to

Sort By:
Pageof 23
Journal of Chemical Information and Modeling|August 2, 2016
Selective Inhibition of STAT3 with Respect to STAT1: Insights from Molecular Dynamics and Ensemble Docking SimulationsSemen O Yesylevskyy, Christophe Ramseyer, Marc Pudlo, et al.
Cancers|January 11, 2022
Harnessing Antitumor CD4<sup>+</sup> T Cells for Cancer ImmunotherapyMyriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, et al.
Annals of Gastroenterology|May 23, 2024
Comparison of a selective STAT3 inhibitor with a dual STAT3/STAT1 inhibitor using a dextran sulfate sodium murine colitis model: new insight into the debate on selectivityBrice Moulari, Jean-Réné Pallandre, Arnaud Béduneau, et al.
Frontiers in Immunology|July 15, 2021
Epigenetic Reprogramming of CD4<sup>+</sup> Helper T Cells as a Strategy to Improve Anticancer ImmunotherapyElodie Renaude, Marie Kroemer, Christophe Borg, et al.
Bulletin Du Cancer|November 12, 2003
[NK cell-based immunotherapy: new prospects and involvement of dendritic cells]Christophe Borg, Julien Taieb, Magali Terme, et al.
Cancers|August 7, 2021
Present and Future Research on Anal Squamous Cell CarcinomaLaurie Spehner, Jihane Boustani, Luc Cabel, et al.
Cancer Gene Therapy|October 14, 2021
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cellsChrystel Marton, Patricia Mercier-Letondal, Romain Loyon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinomaAntoine Thiery-Vuillemin, Caroline Laheurte, Laura Mansi, et al.
Clinical and Vaccine Immunology : CVI|May 31, 2013
Human monocyte-derived dendritic cells exposed to microorganisms involved in hypersensitivity pneumonitis induce a Th1-polarized immune responseAnne-Pauline Bellanger, Jean-René Pallandre, Christophe Borg, et al.
Oncotarget|June 8, 2018
Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinomaAnne Aarnink, Corentin Richard, Caroline Truntzer, et al.
Pageof 23